View in EDS HTML Full Text PDF Full Text

Glioma drug development benefits from emerging phase 0 and window-of-opportunity trial paradigm.

Saved in:
Bibliographic Details
Title: Glioma drug development benefits from emerging phase 0 and window-of-opportunity trial paradigm.
Authors: Jiang, Shenzhong1 (AUTHOR) shenzhongj1@163.com, Zhong, Chunlong1 (AUTHOR) drchunlongzhong@tongji.edu.cn
Source: Cell Communication & Signaling. 9/25/2025, Vol. 23 Issue 1, p1-17. 17p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:1478811X
DOI:10.1186/s12964-025-02408-4